Allscripts commences public offering on behalf of Misys plc

Allscripts-Misys Healthcare Solutions, Inc. (Nasdaq: MDRX), the leading provider of clinical software, information and connectivity solutions for physicians, today announced that it has commenced an underwritten public offering of 25,000,000 shares of its common stock on behalf of certain wholly-owned subsidiaries of Misys plc, Allscripts' majority stockholder.  The shares are being sold by Misys to reduce its equity stake in Allscripts pursuant to the Framework Agreement between Misys and Allscripts, as previously announced in connection with Allscripts' pending merger with Eclipsys Corporation (Nasdaq: ECLP).  The offering includes an option for the underwriters to purchase up to 3,750,000 additional shares from the selling stockholders to cover over-allotments, if any).

Allscripts will not sell any shares in the offering and will not receive any proceeds from the offering.

Credit Suisse, Barclays Capital, J.P. Morgan and UBS Investment Bank will act as joint book-running managers of the offering.

A shelf registration statement relating to the offering of the common shares has been filed with the U.S. Securities and Exchange Commission and has become effective.  The offer is being made by the selling stockholders only by means of a prospectus supplement and accompanying prospectus, forming an effective part of the registration statement. Before investing, you should read the prospectus supplement and the accompanying prospectus for information about Allscripts, Misys and this offering.